MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04272nas a22003257a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210430124251.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m|||||r|||| 00| 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
171219t2008 sp ||||| |||| 00| 0 spa | |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1138-7262 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
Salus Infirmorum |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Manejo de la inmunoterapia con neumoalergenos:¿Qué conocen los pacientes? = |
| Remainder of title |
Management of immunotherapy with pneumoallergens. How much do patients know? / |
| Statement of responsibility, etc. |
Ana Belén Yebra Ludeña, Carmen Campos Rivas, Carolina Domingo López, Yolanda García Estríngana |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Este artículo se encuentra disponible en su edición impresa. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Bibliografía: p.50 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Objetivo: analizar el grado de conocimiento de los pacientes en tratamiento con inmunoterapia a neumoalergenos (IT), sobre las recomendaciones de la Sociedad Española de Alergia e Inmunología Clínica (SEAIC).<br/>Material y métodos: estudio descriptivo de corte de pacientes que acuden consecutivamente a administrarse IT a la Unidad de Alergia de la Fundación Hospital Alcorcón desde febrero hasta abril de 2006.<br/>La recogida de datos se realizó mediante un cuestionario estructurado con preguntas cerradas. <br/>Resultados: se cumplimentaron los 134 cuestionarios entregados. El 96,3% recibió información previa al inicio del tratamiento, un 41% fue informado sólo por el médico. El 21,6% indicó correctamente las condiciones previas a la administración de IT y el 61,6% las recomendaciones posteriores. No presentar catarro (70,9%) y permanecer en observación 30 minutos (97%) fueron las más conocidas respectivamente.<br/>El 51,5% identificó los síntomas de alerta de los que debe informar a la enfermera antes de abandonar el centro sanitario. Los más reconocidos fueron la urticaria (94%) y la dificultad respiratoria (97%)<br/>Ante una reacción tardía sabían cómo actuar el 56,7%.<br/>Se observó que los pacientes que llevan en tratamiento menos de 1 año tienen porcentajes mayores de respuestas correctas en los cuatro apartados evaluados en el cuestionario.<br/>Conclusiones: la información al paciente previa al inicio de su tratamiento de IT es una práctica generalizada en nuestra unidad, pero es necesario mejorar la participación de la enfermera. <br/>Las situaciones que implican mayor riesgo son las que mejor identifican los pacientes. |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Objective: to analyse patient knowledge regarding immunotherapy with pneumoallergens (IT) as recommended <br/>by the Spanish Society of Allergy and Clinical Immunology (SEAIC).<br/>Material and methods: a cut-descriptive study of patients that came consecutively to the Allergy Unit of the Hospital Alcorcón Foundation to have IT administered from february to april 2006.<br/>Data were collected using a structured questionnaire with closed questions. <br/>Results: 134 questionnaires were filled out. 96,3% of patients were informed prior to receiving treatment; only 41% were informed by the doctor. 21,6% indicated the conditions prior to the administration of the IT correctly and 61,6% the conditions following the administration of IT. The most common recommendations were: no flu symptoms (70,9%) and to remain under observation for 30 minutes (97%) respectively. <br/>51,5% identified the alerting symptoms to be reported to the nurse before leaving the health centre. Symptoms most frequently identified were: urticaria (94%) and breathing difficulty (97%).<br/>In the event of a late reaction, 56,7% knew what to do. <br/>Patients who had been on treatment for less than a year were observed to have a higher rate of correct answers in the four sections evaluated in the questionnaire.<br/>Conclusions: informing the patient prior to the administration of IT is a common practice in our unit. However, it is necessary to improve the involvement of the nurse. <br/>Situations involving greater risk are the best identified by patients. |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
alergia |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
inmunoterapia |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
educación sanitaria |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
neumoalergeno |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
atención primaria |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
allergy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immunotherapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
healthcare education |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pneumoallergen |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
primary care |
| 773 ## - HOST ITEM ENTRY |
|---|
| Related parts |
-- 2008 (mar) v. 11, n. 2 p. 50-55 |
| Title |
Metas de enfermería. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Universal Decimal Classification |
| Koha item type |
Artículo de revista |
